Jiménez-Ruiz A, Cárdenas-Sáenz O, Ruiz-Sandoval JL

Language: Spanish
References: 18
Page: 472-479
PDF size: 517.76 Kb.

ABSTRACT

Background: paraneoplastic neurological syndromes are disorders associated with neoplasias, generally from autoantibodies produced by the tumor itself that cause crossed immunity with antigens in the central nervous system. A new neuropsychiatric disease was described recently in young women with ovarian teratoma that produce antibodies against the N-methyl-D-aspartate receptor that is part of the spectrum of limbic encephalitis.
Clinic case: 20 year old patient with a significant neuropsychiatric picture with a final diagnosis of limbic encephalitis from anti rNMDA antibodies secondary to ovarian teratoma, and total remission of the neurological picture after multimodal treatment.
Conclusion: to our knowledge it is the first case of anti rNMDA limbic encephalitis due to ovarian teratoma reported with complete remission of the picture after multimodal treatment with surgery, immunosuppression and immunomodulation.

REFERENCES

1. Didelot A, Honnorat J. Paraneoplastic disorders of the central and peripheral nervous systems. Handbook of ClinicalNeurolology. 2nd ed. Oxford 2014;121:1159-79.

2. Zaborowski MP, Spaczynski M, Nowak-Markwitz E, Michalak S. Paraneoplastic neurological syndromes associated with ovarian tumors. J Cancer Res ClinOncol. 2015; 141:99-108.

3. Revilla F, McMasters M, Kobet C, Espay A. Encephalitis associated with NMDA receptor antibodies: Recognizing a novel neuropsychiatric syndrome. Rev Neuropsiquiatr2010.73: 20-25.

4. Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A et al. Paraneoplatic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007;61:25-36.

5. Kusuhara T, Shoji H, Kaji M, Ayabe M, Hino H. Nonherpetic acute limbic encephalitis. Rinsho Shinkeigaku 1994;34:1083-1088.

6. Rosenfeld M, Dalmau J. Anti–NMDA-Receptor Encephalitis and Other Synaptic Autoimmune Disorders. Curr Treat Options Neurol 2011; 13: 324–332.

7. Lang B, Christian G, Bien G, Vincent A. N-methyl-Daspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain Journal of Neurology 2010; 133: 1655–1667.

8. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld M, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011; 10: 63–74.

9. Lizuka T, Sakai F, Monzen T, Yoshii S, Ligaya M, Suzuki K, MD, Lynch D.R., Suzuki N et al. Anti-NMDA receptor encephalitis in Japan: Long-term outcome without tumor removal. Neurology2008; 70: 504–511.

10. Dalmau J, Tüzün E, Wu HY, Masjuan J, Rossi JE, Voloschin A et al.Paraneoplastic Anti–N-methyl-D-aspartate Receptor Encephalitis Associated with Ovarian Teratoma. Ann Neurol 2007; 61: 25–36.

11. Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7: 1091–1098.

12. Sansing LH, Tüzün E, Ko MW, Baccon J, Lynch DR, Dalmau J. A patient with encephalitis associated with NMDA receptor antibodies.Nat ClinPractNeurol2007; 3:291-6.

13. Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Lizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. LancetNeurol 2013; 12:157-65

14. Bataller L, Kleopa KA, Wu GF, Rossi JE, Rosenfeld MR, Dalmau J. Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes.J NeurolNeurosurg Psychiatry2007; 78:381-5.

15. González-Valcárcel J, Rosenfeld MR, Dalmau J. Differential Diagnosis in encephalitis NMDA receptor antibodies. Neurology 2010; 25: 409-413.

16. Dale RC, Irani SR, Brilot F, Pillai S, Webster R, Gill D, et al. NMDA receptor antibodies in pediatric dyskinetic encephalitis lethargica. Ann Neurol 2009; 66: 704-9.

17. Mann A, Grebenciucova E, Lukas R. Anti- N-methyl- D-aspartate receptor encephalitis: diagnosis, optimal management, and challenges. Ther Clin Risk Manag 2014;10:517-25.

18. Briones-Landa CH, Ayala-Yáñez R,Leroy-López L. Comparación del tratamiento laparoscópico vs laparotomía en teratomas ováricos. Ginecol Obstet Mex 2010;78:527- 532.